Picture of Surgery Partners logo

SGRY — Surgery Partners News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Surgery Partners Q1 results beat estimates

Overview

US short-stay surgical facility operator's Q1 revenue rose 4.5%, beating analyst expectations

Adjusted EPS and adjusted EBITDA for Q1 both beat analyst expectations

Company reaffirmed full-year 2026 revenue and adjusted EBITDA guidance

Outlook

Surgery Partners sees 2026 revenue between $3.35 bln and $3.45 bln

Company expects 2026 Adjusted EBITDA of at least $530 mln

Company says cost management and physician recruitment are key to meeting 2026 targets

Result Drivers

REVENUE PER CASE - Q1 same-facility revenue growth was driven by a 3.8% increase in revenue per case

CASE VOLUME - Same-facility cases rose 0.6% year-over-year, contributing to revenue growth

COST MANAGEMENT - Management cited cost management discipline and portfolio optimization as key operational focuses

Company press release: ID:nGNX8CP8dx

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueBeat$810.90 mln$797.89 mln (11 Analysts)
Q1 Adjusted EPSBeat-$0.03-$0.12 (12 Analysts)
Q1 Adjusted EBITDABeat$102.30 mln$100.79 mln (11 Analysts)
Q1 Adjusted EBITDA Margin12.60%
Q1 Operating Income$65.80 mln
Q1 Pretax Profit-$3.30 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Surgery Partners Inc is $19.00, about 33.8% above its May 4 closing price of $14.20 The stock recently traded at 48 times the next 12-month earnings vs. a P/E of 20 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Surgery Partners

See all news